Article
Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
2024-05-10
Abstract excerpt
The cannabinoid receptor type 1 (CB 1 R) is a promising therapeutic target for various neurodegenerative diseases, including HIV-1-associated neurocognitive disorder (HAND). However, the therapeutic potential of CB 1 R by direct activation is limited due to its psychoactive side effects. Therefore, research has focused on indirectly activating the CB 1 R by utilizing positive allosteric modulators (PAMs). Studi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2990574d-5391-573d-ae21-127f7fc009fa
- DOI
- 10.1101/2024.05.10.593514
